Isolating cognitive and neurologic HIV effects in substance-dependent, confounded cohorts: A pilot study

Journal of the International Neuropsychological Society

Volumn 19, Issue 4, 2013, Pages 463-473

  Byrd, Desiree A ^a   Robinson Papp, Jessica ^a   Mindt, Monica Rivera ^a,b   Mintz, Letty ^a   Elliott, Kathryn ^a   Lighty, Quenesha ^c   Morgello, Susan ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b FORDHAM UNIVERSITY   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

AIDS; Cognition; confounds; illicit drugs; motor dysfunction; neuropsychological tests

Indexed keywords

EID: 84876736417     PISSN: 13556177     EISSN: 14697661     Source Type: Journal    
DOI: 10.1017/S1355617712001634     Document Type: Article

References (64)

1. Baldewicz, T.T., Leserman, J., Silva, S.G., Petitto, J., Golden, R.N., Perkins, D.O., yEvans, D.L. (2004). Changes in neuropsychological functioning with progression of HIV-1 infection: Results of an 8-year longitudinal investigation. AIDS and Behavior, 8(3), 345-355
2. Basso, M., & Bronstein, R. (2000). Neurobehavioural consequences of substance abuse and HIV infection. Psychopharmacology, 14(3), 228-237
3. Basso, M., & Bronstein, R. (2003). Effects of past noninjection drug abuse upon executive function and working memory in HIV infection. Journal of Clinical and Experimental Neuropsychology, 25(7), 893-903
4. Bell, J., Arango, J., & Anthony, I. (2006). Neurobiology of multiple insults: HIV-1-Associated brain disorders in those who use illicit drugs. Journal of Neuroimmune Pharmacology, 1(2), 182-191
5. Bell, J.E., Brettle, R.P., Chiswick, A.A., & Simmonds, P.P. (1998). HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS: Effect of neocortical involvement. Brain, 121(11), 2043-2052
6. Bing, E., Burnam, M., Longshore, D., Fleishman, J., Sherbourne, C., London, A., Shapiro, M. (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry, 58(8), 721-728
7. Brown, E., Prager, J., Lee, H., & Ramsey, R. (1992). CNS complications of cocaine abuse: Prevalence, pathophysiology, and neuroradiology. AJR American Journal of Roentgenology, 159(1), 137-147
8. Burnam, M., Bing, E., Morton, S., Sherbourne, C., Fleishman, J., London, A., Shapiro, M. (2001). Use of mental health and substance abuse treatment services among adults with HIV in the United States. Archives of General Psychiatry, 58(8), 729-736
9. Buttner, A. (2011). Review: The neuropathology of drug abuse. Neuropathology and Applied Neurobiology, 37(2), 118-134
10. Byrd, D., Fellows, R., Morgello, S., Franklin, D., Heaton, R., Deutsch, R., Grant, I. (2011). Neurocognitive impact of substance use in HIV infection. Journal of Acquired Immune Deficiency Syndromes, 58(2), 154-162
11. Centers for Disease Control and Prevention (CDC) (2007). HIV prevalence among selected populations: High-risk populations. Retrieved from CDC Website: Http://www.cdc.gov/hiv/topics/ testing/resources/reports/hiv-prevalence/high- risk.htm
12. Chana, G., Everall, I., Crews, L., Langford, D., Adame, A., Grant, I., Masliah, E. (2006). Cognitive deficits and degeneration of interneurons in HIV1 methamphetamine users. Neurology, 67(8), 1486-1489
13. Concha, M., Graham, N., Munoz, A., Vlahov, D., Royal, W., Updike, M.,yMcArthur, J. (1992). Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivity. American Journal of Epidemiology, 136(11), 1338-1348
14. Concha, M., Selnes, O.A., Vlahov, D., Nance-Sproson, T., Updike, M., Royal, W.,yMcArthur, J.C. (1997). Comparison of neuropsychological performance between AIDS-free injecting drug users and homosexual men. Neuroepidemiology, 16(2), 78-85
15. Darke, S., McDonald, S., Kaye, S., & Torok, M. (2012). Comparative patterns of cognitive performance amongst opioid maintenance patients, abstinent opioid users and non-opioid users. Drug and Alcohol Dependence, 126, 309-315
16. Del Pesce,M., Franciolini, B., Censori, B., Bartolini, M., Ancarani, F., Petrelli, E., & Provinciali, L. (1993). Cognitive behavior in asymptomatic (CDC stage II and III) HIV-seropositive intravenous drug users (IVDUs). Italian Journal of Neurological Sciences, 4(9), 619-625
17. Devlin, K.N., Gongvatana, A., Clark, U.S., Chasman, J.D., Westbrook, M.L., Tashima, K.T., & Cohen, R.A. (2012). Neurocognitive effects of HIV, hepatitis C, and substance use history. Journal of The International Neuropsychological Society, 18(1), 68-78
18. Durvasula, R., Myers, H., Satz, P., Miller, E., Morgenstern, H., Richardson, M., Forney, D. (2000). HIV-1, cocaine, and neuropsychological performance in African American men. Journal of the International Neuropsychological Society, 6(3), 322-335
19. Fellows, R.P., Byrd, D.A., Elliott, K., Robinson-Papp, J., Rivera Mindt, M., & Morgello, S. (2012). Distal sensory polyneuropathy is associated with neuropsychological test performance among persons with HIV. Journal of the International Neuropsychological Society, 19, 1-10
20. Fernández-Serrano, M., Pérez-García, M., Río-Valle, J., & Verdejo-García, A. (2010). Neuropsychological consequences of alcohol and drug abuse on different components of executive functions. Journal of Psychopharmacology, 24(9), 1317-1332
21. Friedman, H., Newton, C., & Klein, T. (2003). Microbial infections, immunomodulation, and drugs of abuse. Clinical Microbiology Reviews, 16(2), 209-219
22. Garavan, H., Kaufman, J., & Hester, R. (2008). Acute effects of cocaine on the neurobiology of cognitive control. Philosophical Transactions of the Royal Society of London B: Biological Sciences, 363(1507), 3267-3276
23. Gonzalez, R., & Cherner, M. (2008). Co-factors in HIV neurobehavioural disturbances: Substance abuse, hepatitis C and aging. International Review of Psychiatry, 20(1), 49-60
24. Gruber, S., Silveri, M., & Yurgelun-Todd, D. (2007). Neuropsychological consequences of opiate use. Neuropsychology Review, 17(3), 299-315
25. Hasin, D., Trautman, K., Miele, G., Samet, S., Smith, M., & Endicott, J. (1996). Psychiatric Research Interview for Substance and Mental Disorders (PRISM): Reliability for substance abusers. The American Journal of Psychiatry, 153(9), 1195-1201
26. Heaton, R.K., Clifford, D.B., Franklin, D.R., Woods, S.P., Ake, C.C., Vaida, F.F., Grant, I.I. (2010). HIV-Associated neurocognitive disorders persist in the era of potent antiretroviral therapy: Charter study. Neurology, 75(23), 2087-2096
27. Janssen, R.S., Cornblath, D.R., Epstein, L.G., & Foa, R.P. (1991). Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-Type 1 (HIV-1) infection. Report of a working group of the American Academy of Neurology AIDS task force. Neurology, 41, 778-785
28. Kalechstein, A., & van Gorp, W. (2007) (Eds.). Neuropsychology and substance use: State of the art and future directions. Philadelphia, PA: Taylor & Francis
29. Koike, H., Iijima, M., Sugiura, M., Mori, K., Hattori, N., Ito, H.,y Sobue, G. (2003). Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy. Annals of Neurology, 54(1), 19-29
30. Levine, A.J., Hardy, D.J., Miller, E., Castellon, S.A., Longshore, D., & Hinkin, C.H. (2006). The effect of recent stimulant use on sustained attention in HIV-infected adults. Journal of Clinical and Experimental Neuropsychology, 28(1), 29-42
31. Liu, H., Hao, Y., Kaneko, Y., Ouyang, X., Zhang, Y., Xu, L., Liu, Z. (2009). Frontal and cingulate gray matter volume reduction in heroin dependence: Optimized voxel-Based morphometry. Psychiatry and Clinical Neurosciences, 63(4), 563-568
32. Llorente, A.M., Miller, E.N., D'Elia, L.F., Selnes, O.A., Wesch, J., Becker, J.T., & Satz, P. (1998). Slowed information processing in HIV-1 disease. Journal of Clinical and Experimental Neuropsychology, 20(1), 60-72
33. Lundqvist, T. (2010). Imaging cognitive deficits in drug abuse. Current Topics in Behavioral Neurosciences, 3, 247-275
34. Manly, J.J., Byrd, D., Touradji, P., Sanchez, D., & Stern, Y. (2004). Literacy and cognitive change among ethnically diverse elders. International Journal of Psychology, 39(1), 47-60
35. Manly, J.J., Jacobs, D.M., Sano, M., Bell, K., Merchant, C.A., Small, S.A. & Stern, Y. (1998). Cognitive test performance among nondemented elderly African Americans and Whites. Neurology, 50, 1238-1245
36. Manly, J.J., Jacobs, D., Touradji, P., Small, S., & Stern, Y. (2002). Reading level attenuates differences in neuropsychological test performance between African American and White elders. Journal of the International Neuropsychological Society, 8, 341-348
37. Martin, E.M., Pitrak, D.L., Rains, N., Grbesic, S., Pursell, K., Nunnally, G., & Bechara, A. (2003). Delayed nonmatch-Tosample performance in HIV-seropositive and HIV-seronegative polydrug abusers. Neuropsychology, 17(2), 283-288
38. Martin-Thormeyer, E., & Paul, R. (2009). Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: Neurocognitive and neuroimaging features. Neuropsychology Review, 19(2), 215-231
39. Mintzer, M.Z., & Stitzer, M.L. (2002). Cognitive impairment in methadone maintenance patients. Drug and Alcohol Dependence, 67(1), 41-51
40. Mintzer, M.Z., Copersino, M.L., & Stitzer, M.L. (2005). Opioid abuse and cognitive performance. Drug and Alcohol Dependence, 78(2), 225-230
41. Morgello, S., Estanislao, L., Simpson, D., Geraci, A., DiRocco, A., Gerits, P., Sharp, V. (2004). HIV-Associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: The Manhattan HIV Brain Bank. Archives of Neurology, 61(4), 546-551
42. National Institute on Drug Abuse (NIDA) (2011, July). NIDA infofacts: Drug abuse and the link to HIV/AIDS and other infectious diseases. Retrieved from NIDA Website: Http:// www.drugabuse.gov/sites/default/files/drugaids.pdf
43. Navia, B., Jordan, B., & Price, R. (1986). The AIDS dementia complex: I. Clinical features. Annals of Neurology, 19(6), 517-524
44. Neiman, J., Haapaniemi, H., & Hillbom, M. (2000). Neurological complications of drug abuse: Pathophysiological mechanisms. European Journal of Neurology, 7(6), 595-606
45. Pace-Schott, E., Morgan, P.T., Malison, R.T., Hart, C.L., Edgar, C., Walker, M., & Stickgold, R. (2008). Cocaine users differ from normals on cognitive tasks which show poorer performance during drug abstinence. The American Journal of Drug and Alcohol Abuse, 34, 109-121
46. Poon, H.F., Abdullah, L., Mullan, M.A., & Crawford, F.C. (2007). Cocaine-induced oxidative stress precedes cell death in human neuronal progenitor cells. Neurochemistry International, 50, 69-73
47. Reger, M., Welsh, R., Razani, J., Martin, D.J., & Boone, K.B. (2002). A meta-Analysis of the neuropsychological sequelae of HIV infection. Journal of the International Neuropsychological Society, 8, 410-424
48. Reinhard, M.J., Hinkin, C.H., Barclay, T.R., Levine, A.J., Marion, S., Castellon, S.A., Myers, H. (2007). Discrepancies between self-report and objective measures for stimulant drug use in HIV: Cognitive medication adherence and psychological correlates. Addictive Behaviors, 32(12), 2727-2736
49. Richter, R., Pearson, J., Bruun, B., Challenor, Y., Brust, J., & Baden, M. (1973). Neurological complications of addiction to heroin. Bulletin of the New York Academy of Medicine, 49(1), 3-21
50. Rippeth, J., Heaton, R., Carey, C., Marcotte, T., Moore, D., Gonzalez, R.,yGrant, I. (2004). Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. Journal of the International Neuropsychological Society, 10(1), 1-14
51. Robinson-Papp, J., Byrd, D., Rivera Mindt, M., Oden, N.L., Cohen, G., Simpson, D.M., & Morgello, S. for the Manhattan HIV Brain Bank. (2008). Motor function and HIV-Associated cognitive impairment in a HAART era cohort. Archives of Neurology, 65(8), 1096-1101
52. Ryan, E., Baird, R., Mindt, M., Byrd, D., Monzones, J., & Bank, S. (2005). Neuropsychological impairment in racial/ethnic minorities with HIV infection and low literacy levels: Effects of education and reading level in participant characterization. Journal of the International Neuropsychological Society, 11(7), 889-898
53. Schlaepfer, T.E., Lancaster, E., Heidbreder, R., Strain, E.C., Kosel, M., Fisch, H.U., & Pearlson, G.D. (2006). Decreased frontal white-matter volume in chronic substance abuse. International Journal of Neuropsychopharmacology, 9, 147-153
54. Scott, J., Woods, S., Matt, G., Meyer, R., Heaton, R., Atkinson, J., & Grant, I. (2007). Neurocognitive effects of methamphetamine: A critical review and meta-Analysis. Neuropsychology Review, 17(3), 275-297
55. Selnes, O., Galai, N., McArthur, J., Cohn, S., Royal, W., Esposito, D., & Vlahov, D. (1997). HIV infection and cognition in intravenous drug users: Long-Term follow-up. Neurology, 48(1), 223-230
56. Soyka, M., Lieb, M., Kagerer, S., Zingg, C., Koller, G., Lehnert, P., Hennig-Fast, K. (2008). Cognitive functioning during methadone and buprenorphine treatment: Results of a randomized clinical trial. Journal of Clinical Psychopharmacology, 28(6), 699-703
57. Venkatesan, A., Nath, A., Ming, G.I., & Song, H. (2007). Adult hippocampal neurogenesis: Regulation by HIV and drugs of abuse. Cellular and Molecular Life Sciences, 64(16), 2120-2132
58. Verdejo, A., Toribio, Y., Orozco, C., Puente, K., & Pérez-García, M. (2005). Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers. Drug and Alcohol Dependence, 78(3), 283-288
59. Yuan, Y., Zhu, Z., Shi, J., Zou, Z., Yuan, F., Liu, Y.,yWeng, X. (2009). Gray matter density negatively correlates with duration of heroin use in young lifetime heroin-dependent individuals. Brain and Cognition, 71(3), 223-228
60. Wiegmann, D.A., Stanny, R.R., McKay, D.L., Neri, D.F., & McCardie, A.H. (1996). Methamphetamine effects on cognitive processing during extended wakefulness. International Journal of Aviation Psychology, 6(4), 379-397
61. Welch, K.A. (2011). Neurological complications of alcohol and misuse of drugs. Practical Neurology, 11, 206-219
62. Woods, S., Rippeth, J., Frol, A., Levy, J., Ryan, E., Soukup, V.,y Heaton, R. (2004). Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. Journal of Clinical and Experimental Neuropsychology, 26(6), 759-778
63. Wojna, V., & Nath, A. (2006). Challenges to the diagnosis and management of HIV dementia. The AIDS Reader, 16(11), 615-616
64. Yeung, M., Bhalla, A., & Birns, J. (2011). Recreational drug misuse and stroke. Current Drug Abuse Reviews, 4(4), 286-291